deshe family accelerator fund
EBRP is establishing the Deshe Family Accelerator Fund (DFAF) dedicated towards funding for-profit preclinical & clinical stage EB therapies, products and potential cures. These are later stage assets that have larger financial needs and the potential for both delivering therapeutics to the EB community and creating a financial return for EBRP. These therapies will be within existing companies or EBRP can help in the formation of new companies. The earlier stage science will have been de-risked via previous work enabling an investment decision-making process around each project. Consistent with EBRP's current venture philanthropy practices, any project funded must provide a meaningful clinical benefit to those living with EB. The goal is to accelerate EB therapies through the clinical trial stage with larger fundings that can be leveraged and provide a return to EBRP to continue funding research until a cure is found.